30.44
Edgewise Therapeutics Inc Aktie (EWTX) Neueste Nachrichten
Stifel raises Edgewise Therapeutics stock price target on trial data timeline - Investing.com Canada
Edgewise Therapeutics, Inc. SEC 10-K Report - TradingView
Assessing Edgewise Therapeutics (EWTX) Valuation After Strong Multi‑Year Returns And Recent Share Price Momentum - Yahoo Finance
Edgewise Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results with Strong Progress Across Muscular Dystrophy and Cardiovascular Programs - PR Newswire
Edgewise Therapeutics (NASDAQ:EWTX) Reaches New 52-Week HighStill a Buy? - MarketBeat
Edgewise Therapeutics stock hits 52-week high at $31.39 - Investing.com
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: Target Price Suggests 26.84% Upside for Biotech Innovator - DirectorsTalk Interviews
How Edgewise Therapeutics Inc. (EWTX) Affects Rotational Strategy Timing - Stock Traders Daily
Edgewise Therapeutics (EWTX) Projected to Post Earnings on Monday - MarketBeat
Published on: 2026-02-21 16:05:11 - mfd.ru
Aberdeen Group plc Has $10.05 Million Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Forecast Cut: Will Edgewise Therapeutics Inc benefit from current market trendsJuly 2025 PostEarnings & Weekly Breakout Watchlists - baoquankhu1.vn
Aug Summary: Is FLIC on track to beat earningsWeekly Profit Recap & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Edgewise Therapeutics earnings on deck as pipeline advances By Investing.com - Investing.com South Africa
Edgewise Therapeutics earnings on deck as pipeline advances - Investing.com Nigeria
Edgewise Therapeutics, Inc. (EWTX) Stock Analysis: A High-Potential Biotech Play with 27% Upside - DirectorsTalk Interviews
GSA Capital Partners LLP Increases Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Published on: 2026-02-16 03:13:40 - mfd.ru
Is Edgewise Therapeutics Inc. gaining market shareJuly 2025 Reactions & Community Trade Idea Sharing Platform - mfd.ru
What is Edgewise Therapeutics Inc.’s book value per share2025 Fundamental Recap & Reliable Entry Point Trade Alerts - mfd.ru
Edgewise Therapeutics, Inc. (NASDAQ:EWTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Upgraded at Wall Street Zen - MarketBeat
Will Edgewise Therapeutics Inc. stock gain from government policies2025 Fundamental Recap & Reliable Entry Point Trade Alerts - mfd.ru
Edgewise Therapeutics Teases Phase 3 Sevasemten Readout, HCM Data Update at Guggenheim Conference - MarketBeat
(EWTX) and the Role of Price-Sensitive Allocations - Stock Traders Daily
Is Edgewise Therapeutics Inc. stock positioned for long term growthJuly 2025 Review & Low Risk High Reward Trade Ideas - mfd.ru
EWTX: Phase III readouts and new cardiac programs drive momentum, with strong commercial readiness - TradingView
Can Edgewise Therapeutics Inc. reach all time highs this yearJuly 2025 Rallies & Free Accurate Trade Setup Notifications - mfd.ru
Assessing Edgewise Therapeutics (EWTX) Valuation After Recent Share Price Momentum - Yahoo Finance
Edgewise Therapeutics to Present at the Guggenheim Emerging Outlook: Biotech Summit 2026 on February 12, 2026 - PR Newswire
Is Edgewise Therapeutics Inc. subject to activist investor interestJuly 2025 WrapUp & Low Drawdown Trading Techniques - mfd.ru
Why Edgewise Therapeutics Inc. stock remains on watchlistsSwing Trade & Daily Technical Forecast Reports - mfd.ru
Piper Sandler Sticks to Their Buy Rating for Edgewise Therapeutics (EWTX) - The Globe and Mail
Why Edgewise Therapeutics stock crushed the market on Monday - MSN
Edgewise Therapeutics stock hits 52-week high at $30.26 By Investing.com - Investing.com South Africa
Analyst Reiterates Bullish Stance on Edgewise Stock - Intellectia AI
Why Edgewise Therapeutics Stock Crushed the Market on Monday - AOL.com
Edgewise Therapeutics (NASDAQ:EWTX) Sets New 12-Month HighTime to Buy? - MarketBeat
Why Edgewise Therapeutics Stock Crushed the Market on Monday - The Motley Fool
Edgewise Therapeutics stock hits 52-week high at $30.26 - Investing.com Nigeria
Piper Sandler reiterates Overweight rating on Edgewise Therapeutics stock By Investing.com - Investing.com Canada
Piper Sandler reiterates Overweight rating on Edgewise Therapeutics stock - Investing.com
Federated Hermes Inc. Decreases Stock Holdings in Edgewise Therapeutics, Inc. $EWTX - MarketBeat
Edgewise Therapeutics (NASDAQ:EWTX) Downgraded by Wall Street Zen to Sell - MarketBeat
Growth Recap: Can Edgewise Therapeutics Inc expand its profit margins2025 Earnings Impact & Weekly Stock Breakout Alerts - baoquankhu1.vn
Braveheart Bio names Marc Evanchik CSO - The Pharma Letter
Hot Picks: Biotech rebound turns to rare disease catalysts - BNN Bloomberg
Why Edgewise Therapeutics Inc. stock remains undervaluedEarnings Recap Report & Reliable Volume Spike Alerts - mfd.ru
Edgewise Therapeutics (EWTX): Analyst Consensus Reveals A 32% Upside Potential - DirectorsTalk Interviews
Dow Update: What analysts say about Edgewise Therapeutics Inc stockJuly 2025 Review & AI Enhanced Execution Alerts - baoquankhu1.vn
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):